Cerebrospinal Fluid Dopamine Metabolite Ratio (Vmax/Sys)

What This Test Measures

Dopamine is a neurotransmitter involved in movement, motivation, and reward processing. This test evaluates two key dopamine metabolites—likely **3,4-dihydroxyphenylacetic acid (DOPAC)** and **homovanillic acid (HVA)**—by comparing their concentrations in CSF. The ratio reflects dopamine turnover and synaptic activity in the brain’s basal ganglia, which can be disrupted in conditions like Parkinson’s disease, schizophrenia, or other neurodegenerative disorders.

Why It’s Done

A healthcare provider may order this test if symptoms suggest dopamine-related neurological issues, such as movement disorders, psychiatric conditions, or unexplained cognitive changes. It’s often used alongside other diagnostic tests, like MRI or dopamine transporter imaging, to refine treatment plans.

Sample Collection and Preparation

A lumbar puncture (spinal tap) is performed to collect CSF, which is then analyzed in a lab. The test measures the ratio of dopamine metabolites directly from this fluid, requiring specialized processing to avoid contamination or degradation.

Clinical Significance

Abnormal ratios may indicate dopamine dysfunction, potentially pointing to conditions like Parkinson’s disease (low turnover), schizophrenia (altered turnover), or other metabolic or structural brain abnormalities. However, results are interpreted in context with clinical symptoms and other diagnostic findings.